Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells (Q38551344)

4 September 2017

Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells (English)

1 reference

4 September 2017

0 references

Kuwahara T

1

1 reference

PubMed ID

9646289

4 September 2017

Asanami S

series ordinal

2

1 reference

PubMed ID

9646289

4 September 2017

Kubo S

series ordinal

3

1 reference

4 September 2017

1 June 1998

1 reference

4 September 2017

1 reference

4 September 2017

14

1 reference

4 September 2017

6

1 reference

4 September 2017

496-501

1 reference

Infusion thrombophlebitis

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

First choice for total parenteral nutrition: the peripheral route

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Peripheral vein infusion of dextrose/amino acid solutions +/- 20% fat emulsion

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Factors Determining Peripheral Vein Tolerance to Amino Acid Infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Peripheral venous nutrition: the equal relevance of volume load and osmolarity in relation to phlebitis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Experimental infusion thrombophlebitis. Importance of the infusion rate

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Inflammatory Potential of Foreign Particulates in Parenteral Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Peripheral parenteral nutrition: a preliminary report on its efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

A prospective and randomised study comparing the incidence of infusion phlebitis during continuous and cyclic peripheral parenteral nutrition.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Peripheral parenteral nutrition: effect of a standardized compounded mixture on infusion phlebitis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Administration of peripheral parenteral nutrition: a prospective study comparing rotation of venous access sites with ultrafine cannulas.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Effect of transdermal glyceryl trinitrate on the survival of peripheral intravenous infusions: a double-blind prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Peripheral infusion as the route of choice for intravenous nutrition: a prospective two year study.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Effect of pH in glucose infusions on development of thrombophlebitis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Factors influencing endothelial injury and vascular thrombosis after perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

Experimental infusion phlebitis: importance of titratable acidity on phlebitic potential of infusion solution

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2898%2900037-9

7 January 2021

10.1016/S0899-9007(98)00037-9

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

9646289